Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2025-10-14 00:00:00 ET · period of report 2025-10-13 · accession 0001193125-25-238708 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-14 | 2025-10-13 | RARE | Horn Howard | CFO | S - Sale | $31.51 | -7,942 | 98.2K | -7% | -$250.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-13 | S | D | 7,942 | $31.51 | 98,227 | D | — | — | (F1) Represents shares sold to pay required tax withholdings due to the vesting of RSUs. (F2) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |